{"blog": [], "keywords": [{"value": "GW Pharmaceuticals PLC.", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Medical Marijuana", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Epilepsy", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "4", "is_major": "Y"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "5", "is_major": "N"}, {"value": "Colorado", "name": "glocations", "rank": "6", "is_major": "N"}, {"value": "Marijuana", "name": "subject", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/03/15/business/marijuana-based-drug-found-to-reduce-epileptic-seizures.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}], "original": "By ANDREW POLLACK"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/03/15/business/15drug2/15drug2-thumbWide.jpg", "legacy": {"wide": "images/2016/03/15/business/15drug2/15drug2-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/03/15/business/15drug2/15drug2-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/15/business/15drug2/15drug2-articleLarge.jpg", "xlargeheight": "393", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 393}, {"url": "images/2016/03/15/business/15drug2/15drug2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/15/business/15drug2/15drug2-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "1038", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Epidiolex, in its first major clinical trial, reduced convulsive seizures in young patients with Dravet syndrome, according to GW Pharmaceuticals.", "pub_date": "2016-03-15T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Drug Based on Cannabis Meets Goal of Big Trial", "main": "Marijuana-Based Drug Found to Reduce Epileptic Seizures"}, "print_page": "1", "snippet": "Epidiolex, in its first major clinical trial, reduced convulsive seizures in young patients with Dravet syndrome, according to GW Pharmaceuticals.", "_id": "56e6cc1c38f0d82d8fe3a16a", "slideshow_credits": null, "abstract": "GW Pharmaceuticals says its experimental drug Epidiolex, which is derived from marijuana, succeeds in lessening epileptic seizures in its first major medical trial; if approved by regulators, Epidiolex would be first prescription drug in United States extracted from marijuana."}